- Home
- DCOM vs HROW Comparison
DCOM vs HROW Comparison
Compare DCOM & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCOM
- HROW
- Stock Information
- Founded
- DCOM 1864
- HROW 1998
- Country
- DCOM United States
- HROW United States
- Employees
- DCOM N/A
- HROW N/A
- Industry
- DCOM Major Banks
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- DCOM Finance
- HROW Health Care
- Exchange
- DCOM Nasdaq
- HROW Nasdaq
- Market Cap
- DCOM 1.2B
- HROW 1.1B
- IPO Year
- DCOM 1996
- HROW N/A
- Fundamental
- Price
- DCOM $28.00
- HROW $34.37
- Analyst Decision
- DCOM Buy
- HROW Strong Buy
- Analyst Count
- DCOM 4
- HROW 7
- Target Price
- DCOM $33.88
- HROW $61.83
- AVG Volume (30 Days)
- DCOM 300.2K
- HROW 393.6K
- Earning Date
- DCOM 07-24-2025
- HROW 08-06-2025
- Dividend Yield
- DCOM 3.45%
- HROW N/A
- EPS Growth
- DCOM N/A
- HROW N/A
- EPS
- DCOM 0.62
- HROW N/A
- Revenue
- DCOM $295,419,000.00
- HROW $212,858,000.00
- Revenue This Year
- DCOM $45.90
- HROW $44.89
- Revenue Next Year
- DCOM $16.52
- HROW $38.22
- P/E Ratio
- DCOM $46.42
- HROW N/A
- Revenue Growth
- DCOM N/A
- HROW 53.49
- 52 Week Low
- DCOM $21.53
- HROW $20.85
- 52 Week High
- DCOM $37.60
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- DCOM 53.40
- HROW 64.33
- Support Level
- DCOM $27.93
- HROW $30.81
- Resistance Level
- DCOM $29.26
- HROW $37.27
- Average True Range (ATR)
- DCOM 0.76
- HROW 1.50
- MACD
- DCOM 0.07
- HROW 0.27
- Stochastic Oscillator
- DCOM 63.58
- HROW 61.28
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.